Ulrika Essner retweeted
Before Abilify, I was housebound.
At 4mg, I was able to walk 0.2 miles to a bench near my house, rest, and walk back.
At 6mg, I was able to walk 0.5 miles, rest, and then back.
But the restlessness was too much, even at 5mg, so I have gone back down to 4.
#LongCovid #MECFS
I am now at 4mg of Abilify per day (up from 2 in Feb), and I am continuing to see benefits in energy and overall well-being.
I will up it to 6mg in a few weeks.
#LongCovid #MECFS
Interesting! But what about LC with ME symptoms fullfilling the Canadian Conscensus Criterias? Still a distinct difference?
University of Valencia researchers studied 50 women and found distinct immune, platelet, and vascular signatures in Long COVID.
A biomarker panel distinguished Long COVID from ME/CFS, fibromyalgia, and controls with an AUC of 0.914.
biorxiv.org/content/10.64898…
1
6
173
Ulrika Essner retweeted
Yet another study detected spike protein in both healthy (5) and LC (8) gut biopsies.
They used spatial transcriptomics to look at the gene expression levels in the gut tissue.
And significantly, this showed that LC patients had a different tissue phenotypes around spike. 1/3
Mycket bra tråd för den som är nyfiken på vad som diskuterades på longcovid-konferensen nyligen i Nice! 👀
Det är väldigt, väldigt många människor som inte blir friska från sin longcovid. Både vuxna i arbetsför ålder, studenter, tonåringar och barn. Mer forskning nu!
Replying to @atranscendedman
Behind every statistic is someone who wanted their life back.
A child missing school. A parent unable to work. Someone watching their world grow smaller.
The science matters because these lives matter.
We need treatments, but we also need to care for people while they wait.
Ulrika Essner retweeted
Psychologists’ Open Letter to Andy Burnham for Biomedical ME Research
- Only published yesterday afternoon, and it’s the most viewed post/page in the last 30 days. Please pass onto any UK psychologist you know.
humanisticsystems.com/me-ope…
Ulrika Essner retweeted
Submissions are still open for a few more weeks for the very severe ME photo gallery that @tink_ina and I are curating:
lcmedata.org/severephotos
We are particularly looking for high-quality, representative photos of Severe ME for projects, articles, and media to use to better represent the suffering of the disease using visuals. Some example submissions of the great ones we've gotten so far can be found below.
Tired of seeing the same lame stock photos of clearly healthy actors draping the back of their hands over their foreheads to represent ME?
@tink_ina and I feel the same way. That's why we're starting a photo gallery showcasing very severe patients that will be promoted to journalists and relevant organizations for use in articles and media.
We need your submissions to help curate the highest quality and most representative photos for this project. If you have photos of yourself or someone you take care of, please submit them: lcmedata.org/severephotos
Ulrika Essner retweeted
Regeneron’s Phase 2 trial in 82 POTS patients found that a single dose of baloncibart reduced standing heart rate by 11.4 bpm versus placebo and improved symptoms.
The antibody blocks NPR1, with biomarkers suggesting increased blood volume.
investor.regeneron.com/news-…
Ulrika Essner retweeted
The silent reality of Long Covid is that many patients are worsening, progressing or destabilising over time. Many progress from mild to moderate and severe.
Thank you to Molly and @AlastairFeeBBC for raising awareness.
bbc.co.uk/news/articles/c8p3…
Ulrika Essner retweeted
Excited to share ChronicleBio’s first clinical trial partnership, with Prolong Pharmaceuticals, evaluating PP-007 (Sanguinate) for post-exertional malaise in ME/CFS.
Heterogeneous diseases need this approach.
Today we are announcing our first clinical trial. We're joining forces with Prolong to evaluate a potential treatment for post exertional malaise (PEM) in #MECFS.
Sanguinate is an investigational intravenous therapy designed to deliver oxygen to deprived tissues, support blood flow, and reduce inflammation. The planned multi-site Phase 2a trial will evaluate the drug in at least 40 patients with first dosing expected mid-2027.
Most trials enroll patients based on symptoms alone, but recruitment for this study will leverage ChronicleBio's proprietary endotype intelligence platform to identify patients whose disease biology suggests they may be more likely to respond.
We are excited for our partnership with Prolong and grateful for the patient community that drives everything we do.
Read More: chroniclebio.com/news/chroni…
Ulrika Essner retweeted
“It's not just oh you know a bit forgot about, it has been like so drastically forgot about, it's unbelievable”
Former Olympic sprinter @BethDobbin on the neglect of #MECFS and the underfunding of research, comparing £6M for ME with £496M for dementia between 2019 and 2024.
Ulrika Essner retweeted
This almost makes me cry. We NEED more of this. $15 million is a great start on research. Long Covid is NOT going away. Finding biometrics and tests would be huge!
youtu.be/IxHlEJ3WUDs?is=IZyA…
Ulrika Essner retweeted
6 months in Germany! 🇩🇪🔬❤️
Months of hard work & new challenges! And next week, I'll be presenting our first results at a conference!
What if SARS-CoV-2 leaves more behind than we think?
Millions of people are still living with #LongCOVID, and we keep fighting to understand why.
Ulrika Essner retweeted
500 Athlete Signatures 🤩⭐️🏅
We’ve had so much interest since our initial athlete letter to the Prime Minister that we’ve now sent a second letter, this time with 500 athletes backing my call to meet with me and fund ME properly (prev 360).
Huge names including David Moyes (we know Andy’s an Everton fan 👀), Millie Bright & so many stars from a variety of sports 🙏🏼 I can’t tell you how grateful I am to every single one of you!!
Please @andyburnham , take an illness that’s been neglected more than almost anything else seriously 🙏🏼 1.35m people in the country estimated to be impacted, that’s a lot of the vote share!! @UKLabour
I know I owe lots of people replies and thanks, please bear with me and thank you so much again ❤️❤️❤️
Ulrika Essner retweeted
Die „Abnehmspritze“ (GLP-1) bei MCAS und ME/CFS? Ja – in Mikrodosierung.
GLP-1 ist ein Darmhormon. Aber seine Rezeptoren sitzen auch auf Immunzellen und auf Mastzellen. Genau da setzen die GLP-1s bei MCAS an.
Es geht hier nicht ums Abnehmen. Mit Mikrodosierung nutzen wir nur eine sehr geringe Dosis – so wenig wie möglich, um die Entzündung zu beruhigen.
In unserer ersten Fallserie (Afrin et al., Am J Med Sci 2025 – ich bin Co-Autorin) haben sich 89 % von 47 MCAS-Patienten deutlich gebessert: weniger Erschöpfung, weniger Brain Fog, weniger Schmerzen. Manche schon nach Stunden.
Das ist eine Fallserie, keine kontrollierte Studie. Mikrodosierung von GLP-1 ist bei MCAS und MECFS off-label – die Dosis wird ganz individuell bestimmt und im Verlauf angepasst.
arztpraxis-aschenbrenner.de/…
#MCAS #MECFS #GLP1 #Mikrodosierung #Tirzepatid
Den som söker han ska finna 👀🦠
Researchers at Stavanger University Hospital studied 96 people and found 19 altered proteins in Long COVID, revealing persistent immune activation and neuroinflammatory signaling despite normal routine tests.
nature.com/articles/s41598-0…
Ulrika Essner retweeted
Really interesting! Great to see this phenotyping work in #LongCovid 🔬
BioVie presented new findings from our Phase 2 ADDRESS-LC trial that suggest two distinct biomarker-defined #LongCOVID endotypes are associated with different patient responses to bezisterim treatment.
See details about our presentation at the @FNIH_Org @NIH RECOVER-TLC workshop here: investors.bioviepharma.com/n…
#LongCOVID $BIVI
Fler läkemedelsstudier för longcovid och ME/cfs i Sverige tack! 🙏
Varför låta andra länder stå för allt arbete? Svenska patienter behöver också få en chans!
コロナ後遺症患者46人を対象としたJAK阻害薬「アブロシチニブ」の第2a相試験で、12週間の投与により疲労スコアが大幅に改善。炎症やT細胞の免疫疲弊に関連する経路も減少した。慢性炎症と免疫疲弊の関与を示唆する結果だが、小規模試験であり、今後さらなる検証が必要。
thesicktimes.org/2026/11/04/…
Ulrika Essner retweeted
This is such a lonely illness. The person I’m forced to be is not the be person I am☹️ #MECFS

































